Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Thursday, October 24, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
GlobalFoundries & NXP Unveil Next-Gen 22FDX Solutions for Automotive & IoT
ORBCOMM Unveils First Native Satellite Tracker for OGx Network
Konexial Teams Up with Lytx® to Transform Fleet Management
Integral Molecular Wins $8M NIAID Contract to Fight Emerging Viruses
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Alpha-9 Oncology
Alpha-9 Oncology
Biotechnology
Alpha-9 Oncology Secures $175 Million in Oversubscribed Series C Financing
News Desk
-
October 24, 2024
Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an oversubscribed $175 million Series...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
GlobalFoundries & NXP Unveil Next-Gen 22FDX Solutions for Automotive & IoT
ORBCOMM Unveils First Native Satellite Tracker for OGx Network
Konexial Teams Up with Lytx® to Transform Fleet Management
Load more
